Nevada Cancer Research Foundation

Carson-Tahoe Hospital

TREATMENT PROTOCOLS

Table of Contents

bulletBRAIN
bulletBREAST
bulletGASTROINTESTINAL
bulletGENITOURINARY
bulletGYNECOLOGICAL
bulletHEAD AND NECK
bulletLEUKEMIA
bulletLYMPHOMA
bulletLUNG

HOME

BRAIN

bullet0614 - A RANDOMIZED, PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF MEMANTINE FOR PREVENTION OF COGNATIVE DYSFUNCTION IN PATIENTS RECEIVING WHOLE-BRAIN RADIOTHERAPY
Back to Top

BREAST

ADJUVANT

bulletB-39/0413 - A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
bulletpacct-1 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial
 

METASTATIC

bulletS0500 - A RANDOMIZED PHASE III TRIAL TO TEST THE STRATEGY OF CHANGING THERAPY VERSUS MAINTAINING THERAPY FOR METASTATIC BREAST CANCER PATIENTS WHO HAVE ELEVATED CIRCULATING TUMOR CELL LEVELS AT FIRST FOLLOW-UP ASSESSMENT
Back to Top

GASTROINTESTINAL

ANAL CANAL

bullet 

COLORECTAL

bullet 

COLON

bulletE5202 - A RANDOMIZED PHASE III STUDY COMPARING 5-FU, LEUCOVORIN AND OXALIPLATIN VERSUS 5-FU, LEUCOVORIN, OXALIPLATIN AND BEVACIZUMAB IN PATIENTS WITH STAGE II COLON CANCER AT HIGH RISK FOR RECURRENCE TO DETERMINE PROSPECTIVELY THE PROGNOSTIC VALUE OF MOLECULAR MARKERS
Back to Top

GENITOURINARY

RENAL

bulletE2805 -  A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma

PROSTATE

bullet
Back to Top

GYNECOLOGICAL

CERVICAL

bullet
Back to Top

HEAD AND NECK

bullet 
Back to Top

LEUKEMIA

bullet10501 - A PHASE III INTERGROUP CLL STUDY OF ASYMPTOMATIC PATIENTS WITH UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RANDOMIZED TO EARLY INTERVENTION VERSUS OBSERVATION WITH LATER TREATMENT IN THE HIGH RISK GENETIC SUBSET WITH IgVH UNMUTATED
Back to Top

LYMPHOMA

NON-HODGKIN'S

bulletE4402 - RANDOMIZED PHASE III TRIAL COMPARING TWO DIFFERENT RITUXIMAB DOSING REGIMENS FOR PATIENTS WITH LOW TUMOR BURDEN INDOLENT NON-HODGKIN'S LYMPHOMA
Back to Top

LUNG

NON-SMALL CELL

SMALL CELL

bullet

 

Back to Top